Charles Schwab’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-149,696
| Closed | -$10.2M | – | 3206 |
|
|
2019
Q3 | $10.2M | Sell |
149,696
-127,813
| -46% | -$8.78M | 0.01% | 1595 |
|
|
2019
Q2 | $16.1M | Buy |
277,509
+34,916
| +14% | +$2.07M | 0.01% | 1285 |
|
|
2019
Q1 | $17M | Buy |
242,593
+10,502
| +5% | +$779K | 0.01% | 1216 |
|
|
2018
Q4 | $14.9M | Sell |
232,091
-28,233
| -11% | -$1.98M | 0.01% | 1176 |
|
|
2018
Q3 | $18.3M | Sell |
260,324
-73,358
| -22% | -$4.29M | 0.01% | 1199 |
|
|
2018
Q2 | $16.8M | Sell |
333,682
-96,944
| -23% | -$3.85M | 0.01% | 1223 |
|
|
2018
Q1 | $13.5M | Sell |
430,626
-24,463
| -5% | -$812K | 0.01% | 1283 |
|
|
2017
Q4 | $15.6M | Sell |
455,089
-48,155
| -10% | -$1.54M | 0.01% | 1166 |
|
|
2017
Q3 | $16.1M | Buy |
503,244
+5,904
| +1% | +$186K | 0.01% | 1085 |
|
|
2017
Q2 | $16.2M | Buy |
497,340
+14,665
| +3% | +$465K | 0.02% | 1016 |
|
|
2017
Q1 | $15.2M | Buy |
482,675
+38,199
| +9% | +$1.13M | 0.02% | 1009 |
|
|
2016
Q4 | $13.1M | Buy |
444,476
+71,562
| +19% | +$2.18M | 0.01% | 1068 |
|
|
2016
Q3 | $10.8M | Buy |
372,914
+245,262
| +192% | +$6.83M | 0.01% | 1117 |
|
|
2016
Q2 | $3.31M | Buy |
127,652
+49,512
| +63% | +$1.32M | ﹤0.01% | 1814 |
|
|
2016
Q1 | $1.94M | Buy |
78,140
+12,375
| +19% | +$340K | ﹤0.01% | 2070 |
|
|
2015
Q4 | $2.31M | Buy |
65,765
+9,308
| +16% | +$249K | ﹤0.01% | 2008 |
|
|
2015
Q3 | $1.2M | Buy |
56,457
+3,301
| +6% | +$85.1K | ﹤0.01% | 2323 |
|
|
2015
Q2 | $1.48M | Buy |
53,156
+1,496
| +3% | +$42.2K | ﹤0.01% | 2237 |
|
|
2015
Q1 | $1.58M | Buy |
51,660
+2,234
| +5% | +$71K | ﹤0.01% | 2181 |
|
|
2014
Q4 | $1.58M | Sell |
49,426
-5,512
| -10% | -$179K | ﹤0.01% | 2143 |
|
|
2014
Q3 | $1.56M | Buy |
54,938
+1,106
| +2% | +$30.8K | ﹤0.01% | 2100 |
|
|
2014
Q2 | $1.48M | Sell |
53,832
-148
| -0.3% | -$3.94K | ﹤0.01% | 2142 |
|
|
2014
Q1 | $1.42M | Buy |
53,980
+5,698
| +12% | +$163K | ﹤0.01% | 2118 |
|
|
2013
Q4 | $1.41M | Buy |
48,282
+5,102
| +12% | +$162K | ﹤0.01% | 2100 |
|
|
2013
Q3 | $1.31M | Buy |
43,180
+1,083
| +3% | +$36.2K | ﹤0.01% | 2076 |
|
|
2013
Q2 | $1.38M | Buy |
+42,097
| New | +$1.38M | ﹤0.01% | 1975 |
|
Charles Schwab's GHDX Position: Q4 2019 in Review
Charles Schwab sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 149,696 shares — an estimated $10.2M sold.
Charles Schwab first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $18.3M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Charles Schwab reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Charles Schwab sold 149,696 Genomic Health, Inc. shares in Q4 2019, an estimated $10.2M.
- Charles Schwab first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Charles Schwab's Genomic Health, Inc. position peaked at $18.3M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.